NEW YORK, NY / ACCESSWIRE / February 6, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Atlas Technical Consultants, Inc. (NASDAQ:ATCX)'s sale to GI Partners for $12.25 per share in cash. If you are an Atlas shareholder, click here to learn more about your rights and options.
AlerisLife Inc. (NASDAQ:ALR)'s sale to ABP Acquisition LLC for $1.31 per share in cash. If you are an AlerisLife shareholder, click here to learn more about your rights and options.
Leap Therapeutics, Inc. (NASDAQ:LPTX)'s merger with Flame Biosciences, Inc. Under the terms of the merger agreement, Leap will issue approximately 19,794,373 shares of its common stock and approximately 136,833 shares of a newly designated Series X non-voting convertible preferred stock to Flame stockholders. If you are a Leap shareholder, click here to learn more about your legal rights and options.
Chembio Diagnostics, Inc. (NASDAQ:CEMI)'s sale to Biosynex SA for $0.45 per share. If you are a Chembio shareholder, click here to learn more about your rights and options.
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
SOURCE: Halper Sadeh LLC